Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

No patient left behind

How healthcare comms helps create rare disease communities

- PMLiVE

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Gains rights to tau-targeting drug ST-501 as part of broader alliance

- PMLiVE

Acacia finally gets FDA okay for first product Barhemsys

Edison analyst predicts drug could reach $387m at peak

Assessing the value of interim analyses in clinical trials

Why its important and when its needed

- PMLiVE

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Advisory committee voted 6-5 in favour of drug

- PMLiVE

Celgene’s Revlimid scores NICE approval in follicular lymphoma

New ‘chemotherapy-free’ treatment for patients with limited options

- PMLiVE

Bedrock Group bolsters team with three key appointments

Andy Jobson, Deborah Blain and Vicky O'Connor join company

- PMLiVE

Menlo slumps as itching drug fails mid-stage trial

Shares in US biotech closed down almost a third after announcement

- PMLiVE

Trial of Amgen, Servier’s heart failure drug clears interim check

Drug could become a $2bn product if approved

Miranda Dini

AVENIR GLOBAL appoints global healthcare lead

Mirandi Dini expands role at communications firm

- PMLiVE

Policy and public health: all the decisions we can’t see

January was a bad month for healthcare in China

- PMLiVE

AXON recognised for ‘excellence in wellbeing’ by Great Place to Work

Healthcare comms company wins recognition for second year in a row

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links